ResearchMoz include new market research report “Frontier Pharma: Fatty Liver Disease – High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products” to its huge collection of research reports.
Fatty liver disease (FLD) comprises a spectrum of chronic liver disorders characterized by excessive lipid accumulation in the liver (steatosis), which may lead to inflammation (steatohepatitis) and fibrosis. It has the potential to progress to end-stage liver diseases such as cirrhosis, liver cancer and liver failure nike air max 270 blanche pas cher , and is also associated with numerous complications and co-morbidities, including cardiovascular and metabolic diseases. FLD can be divided into non-alcoholic FLD (NAFLD) and alcoholic FLD (AFLD), depending on the patent鈥檚 history of alcohol use.
KNOW MORE WITH SAMPLE STUDY @ ;repid=1065937
FLD is the most common chronic liver disease in the world, and its global prevalence has increased rapidly in the past several decades. The worldwide prevalence of FLD is estimated at 20鈥?5% in the general population nike air max 270 rose pas cher , and up to 90% in obese patients. There is a broad consensus to describe the condition as the hepatic manifestation of metabolic syndrome, and it is closely associated with obesity, diabetes and dyslipidemia. NAFLD has become the main driver of the rapid growth of FLD prevalence, mainly due to the rising prevalence of obesity.
FLD is increasingly recognized as a major global health problem. However nike air max 270 rouge pas cher , despite this the FLD market is still in its infancy, with no FDA-approved drugs for this indication, and only a limited number of generic drugs approved in non-US markets in recent years.
Due to the increasing health burden of FLD and the lack of therapeutic options, there is a pressing need to develop pharmacological strategies. This is especially the case for patients with steatohepatitis nike air max 270 noir pas cher , who are at the greatest risk of developing cirrhosis or liver cancer, which can lead to liver failure. Due to the pathophysiological complexity of FLD and its diverse population, different therapeutic agents are likely to be needed to tackle the lipotoxicity, inflammation and fibrogenesis that drive FLD progression.
FLD has an active pipeline and first-in-class products account for a considerable proportion grossiste nike air max 270 , which is very promising considering the level of unmet need and lack of approved treatment options. First-in-class innovation is concentrated heavily at the early drug development stages, and prominent first-in-class molecular targets include nuclear receptors, immune mediators, and molecules involved in lipid synthesis. Additionally grossiste basket air max 270 , the first-in-class targets identified show considerable diversity, reflecting the multifaceted aspects of FLD pathophysiology.
Get more information from Table of Content:
Scope
FLD comprises a diverse patient population with significant unmet
needs
-What is the pathophysiology of FLD?
-What are the common
co-morbidities and complications?
-What are the most significant unmet needs
within the market?
The FLD pipeline is relatively large and has a high degree of first-in-class
innovation
-Which molecule types and molecular targets are most prominent
within the pipeline?
-Which first-in-class targets are most
promising?
-How does the ratio of first-in-class targets to first-in-class
products differ by stage of development and molecular target class?
The FLD deal landscape shows rising deal volumes and considerable investment
opportunities
-Do FLD products attract high deal values?
-Which molecule
types and molecular targets dominate the deals landscape?
-Which
first-in-class pipeline products have no prior involvement in licensing or
co-development deals?
Make An Enquiry @ ;repid=1065937
Reasons to buy
This report will allow you to –
-Appreciate the current clinical and commercial landscapes by considering
disease pathogenesis, etiology, epidemiology grossiste air max 270
flyknit , symptoms, co-morbidities and complications, and treatment
options and algorithms.
-Visualize the composition of the FLD market in terms
of dominant classes of therapies. Key unmet needs are identified to allow a
competitive understanding of gaps in the market.
-Recognize innovative
pipeline trends by analyzing therapies by stage of development, molecule type
and molecular target.
-Assess the therapeutic potential of first-in-class
targets. Using a proprietary matrix tailored to FLD grossiste air max 270
soldes , all first-in-class targets in the pipeline have been
assessed and ranked according to clinical potential. Promising early-stage
targets have been further reviewed in greater detail.
-Consider
first-in-class pipeline products with no prior involvement in licensing and
co-development deals that may represent potential investment opportunities.
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
As a qualified, capable and inte. Cheap MLB
Hats Cheap College
Jerseys Cheap Ultra Boost
Womens Cheap Ultra Boost
Black Cheap Ultra Boost Triple
White Cheap Ultra Boost
Womens Cheap Ultra Boost
Blue Cheap Adidas Ultra
Boost Cheap Adidas NMD Womens
Shoes NMD Pink Shoes For
Sale